Silo Pharma Inc (SILO) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Silo Pharma Inc  (NASDAQ: SILO)


Silo Pharma Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Silo Pharma Inc's ROA in the second quarter of 2026?
Silo Pharma Inc recorded a cumulative net loss of $-4 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -56.35%.

However, within the Healthcare sector 649 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4121, from total ROA ranking in the first quarter of 2026 at 4739.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -9.77 % 20.13 % 67.12 % -24.94 % -17.3 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -4 -5 -4 -5 -5
Return On Assets (TTM) -56.35 % -59.82 % -54.18 % -77.4 % -69.05 %
SILO's Total Ranking # 4121 # 4739 # 4266 # 4260 # 4284
Total Assets (TTM) in million 6 7 12 6 7
Seq. Total Assets Change -15.19 % -43.34 % 94.01 % -3.21 % 12.91 %
Seq. Net Income Change - - - - -

SILO's 5 Years Annual ROA >> Back to SILO Management Effectiveness >> Compare SILO ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 296
Sector # 650
Overall # 4056

Return On Assets Statistics
High Average Low
97.34 %
-221.36 %
-3090.2 %
(Sep 30 2021)   (Dec 31 2012)



  News about Silo Pharma Inc Return on Assets ROA

Silo Pharma Inc. Ventures into Registered Direct Offering, Boosting Future Developments

In recent news, Silo Pharma Inc. (NASDAQ: SILO), a developmental-stage biopharmaceutical company, has announced its entry into a $2.1 million Registered Direct Offering. This move marks a significant milestone for the company and demonstrates its commitment to advancing novel formulations and drug delivery techniques. The offering will fuel Silo Pharma s endeavors in developing cutting-edge therapies to address various healthcare needs. Let s delve deeper into the details surrounding this strategic decision and its potential implications.Silo Pharma s Registered Direct OfferingOn July 19, 2024, Silo Pharma revealed its registration for a $2.1 million Registered Direct Offering under Nasdaq rules. By going the registered direct offering route, the company can raise capital directly from investors, allowing for rapid access to funds without diluting existing shareholders. Silo Pharma is poised to utilize these funds to further progress its ongoing research and development activities.



Financial Statements
Silo Pharma Inc's Assets $ 6 million SILO's Balance sheet
Silo Pharma Inc's Income $ -1 million Quarterly SILO's Income Statement
SILO's Income by Division See SILO's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 67.12 % -28.42 % -11.07 % 10.99 % 635.3 %
Total Assets in million 12 7 10 12 10
Y / Y Net Income Change - - - - -
Net Income in million -4 -4 -4 -4 4
Annual Return On Assets -34.13 % -59.27 % -35.74 % -33.57 % 37.21 %

SILO's 5 Years Annual ROA >> Back to SILO Management Effectiveness >> Compare SILO ROA to its Competitors



More Return On Assets Ratios
SILO's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SILO's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SILO's Competitors
Subscribers only: Roa for Silo Pharma Inc's Suppliers
Subscribers only: Return On Assets for SILO's Customers

You may also want to know
SILO's Roi SILO's Inventory Turnover Ratio SILO's Growth Rates SILO's Dividend Comparisons
SILO's Profitability Ratios SILO's Asset Turnover Ratio SILO's Dividend Growth
SILO's Roe SILO's Valuation Ratios SILO's Financial Strength Ratios SILO's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-26T07:36:46+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.